|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.020 USD | -8.18% |
|
-9.42% | -85.76% |
| 06-02 | NextCure, Inc. - Special Call | |
| 06-01 | NextCure, Inc. Presents Positive SIM0505 Phase 1 Dose Escalation Data In Patients With Gynecologic Cancers At ASCO | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 4.8 | 6.07 | 5.13 |
| Spread/Res. | -57.92% | -66.72% | -60.62% |
| Spread/Supp. | +3.06% | +3.06% | -2.65% |
| Support | 1.96 | 1.96 | 2.075 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NXTC Stock
- Charts NextCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
